Best Value Stocks To Consider - October 9th

Key Points

• MarketBeat’s value-stock screener identified five stocks to watch: Micron Technology, SpaceX, Invesco QQQ, Intel, and Moderna, based on their high recent dollar trading volume among value stocks.
• The companies provide exposure to diverse areas, including memory and semiconductors (Micron and Intel), aerospace and communications (SpaceX), the Nasdaq-100 through an ETF (QQQ), and mRNA vaccines and therapeutics (Moderna).
• Value stocks may offer price appreciation and income if the market recognizes their fundamental worth, but they can remain undervalued or decline if their business fundamentals deteriorate.

Micron Technology, SpaceX, Invesco QQQ, Intel, and Moderna are the five Value stocks to watch today, according to MarketBeat's stock screener tool. Value stocks are shares of companies that appear undervalued relative to their fundamental financial measures, such as earnings, book value, cash flow, or dividends. Investors buy them expecting the market will eventually recognize their worth, potentially producing price appreciation and income, though the stocks may remain undervalued or decline if the company’s fundamentals deteriorate. These companies had the highest dollar trading volume of any Value stocks within the last several days.

Micron Technology (MU)

Micron Technology, Inc. designs, develops, manufactures, and sells memory and storage products worldwide. The company operates through four segments: Compute and Networking Business Unit, Mobile Business Unit, Embedded Business Unit, and Storage Business Unit. It provides memory and storage technologies comprising dynamic random access memory semiconductor devices with low latency that provide high-speed data retrieval; non-volatile and re-writeable semiconductor storage devices; and non-volatile re-writable semiconductor memory devices that provide fast read speeds under the Micron and Crucial brands, as well as through private labels.

Read Our Latest Research Report on MU

SpaceX (SPCX)

Our mission is to build the systems and technologies necessary to make life multiplanetary, to understand the true nature of the universe, and to extend the light of consciousness to the stars. To do this, we have formed the most ambitious, vertically integrated innovation engine on (and off) Earth with unmatched capabilities to rapidly manufacture and launch space-based communications that connect the world, to harness the Sun to power a truth-seeking artificial intelligence that advances scientific discovery, and ultimately to build a base on the Moon and cities on other planets.

Read Our Latest Research Report on SPCX

Invesco QQQ (QQQ)

PowerShares QQQ Trust, Series 1 is a unit investment trust that issues securities called Nasdaq-100 Index Tracking Stock. The Trust's investment objective is to provide investment results that generally correspond to the price and yield performance of the Nasdaq-100 Index. The Trust provides investors with the opportunity to purchase units of beneficial interest in the Trust representing proportionate undivided interests in the portfolio of securities held by the Trust, which consists of substantially all of the securities, in substantially the same weighting, as the component securities of the Nasdaq-100 Index.

Read Our Latest Research Report on QQQ

Intel (INTC)

Intel Corporation designs, develops, manufactures, markets, and sells computing and related products and services worldwide. It operates through Client Computing Group, Data Center and AI, Network and Edge, Mobileye, and Intel Foundry Services segments. The company's products portfolio comprises central processing units and chipsets, system-on-chips (SoCs), and multichip packages; mobile and desktop processors; hardware products comprising graphics processing units (GPUs), domain-specific accelerators, and field programmable gate arrays (FPGAs); and memory and storage, connectivity and networking, and other semiconductor products.

Read Our Latest Research Report on INTC

Moderna (MRNA)

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines.

Read Our Latest Research Report on MRNA

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.